J0889 — Daprodustat, oral, 1 mg, (for esrd on dialysis)
J0889 is a HCPCS Level II code for daprodustat, oral, 1 mg, (for esrd on dialysis). It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J0889 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0889
- Long descriptor
- Daprodustat, oral, 1 mg, (for esrd on dialysis)
- Short descriptor
- Daprodustat oral 1mg esrd
- Added
- October 1, 2023
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 57 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Other carrier priced.
Codes adjacent to J0889
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0889 is not quite right, the correct code is very often within a few positions of it.
- J0881Injection, darbepoetin alfa, 1 microgram (non-esrd use)
- J0882Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)
- J0883Injection, argatroban, 1 mg (for non-esrd use)
- J0884Injection, argatroban, 1 mg (for esrd on dialysis)
- J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
- J0886Injection, epoetin alfa, 1000 units (for esrd on dialysis)terminated
- J0887Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
- J0888Injection, epoetin beta, 1 microgram, (for non esrd use)
- J0890Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894Injection, decitabine, 1 mg
- J0895Injection, deferoxamine mesylate, 500 mg
- J0896Injection, luspatercept-aamt, 0.25 mg
- J0897Injection, denosumab, 1 mg
Questions about J0889
What is HCPCS code J0889?
J0889 is a HCPCS Level II code for daprodustat, oral, 1 mg, (for esrd on dialysis). It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0889?
The CMS HCPCS file marks J0889 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J0889 still valid?
No. J0889 was terminated on December 31, 2025 and should not be used on new claims.